These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 26620718)
1. Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors. Wan Y; Wang J; Sun F; Chen M; Hou X; Fang H Bioorg Med Chem; 2015 Dec; 23(24):7685-93. PubMed ID: 26620718 [TBL] [Abstract][Full Text] [Related]
2. Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino acid side chains. Wan Y; Liu T; Li X; Chen C; Fang H Bioorg Med Chem; 2017 Jan; 25(1):138-152. PubMed ID: 27810438 [TBL] [Abstract][Full Text] [Related]
3. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation. Xu G; Liu T; Zhou Y; Yang X; Fang H Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, stereochemical determination, molecular docking study, in silico pre-ADMET prediction and anti-proliferative activities of indole-pyrimidine derivatives as Mcl-1 inhibitors. Lamie PF; Philoppes JN Bioorg Chem; 2021 Nov; 116():105335. PubMed ID: 34509795 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors. Liu L; Liu R; Yang X; Hou X; Fang H Eur J Med Chem; 2020 Apr; 191():112142. PubMed ID: 32088497 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors. Wan Y; Li Y; Yan C; Wen J; Tang Z Bioorg Chem; 2020 Nov; 104():104217. PubMed ID: 32911192 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors. Fu H; Hou X; Wang L; Dun Y; Yang X; Fang H Bioorg Med Chem Lett; 2015 Nov; 25(22):5265-9. PubMed ID: 26421995 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and preliminary bioactivity studies of 2-thioxo-4-thiazolidinone derivatives as Bcl-2 inhibitors. Wan Y; Wu S; Xiao G; Liu T; Hou X; Chen C; Guan P; Yang X; Fang H Bioorg Med Chem; 2015 May; 23(9):1994-2003. PubMed ID: 25818766 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold. Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors. Wang G; Wang Y; Wang L; Han L; Hou X; Fu H; Fang H Bioorg Med Chem; 2015 Dec; 23(23):7359-65. PubMed ID: 26558516 [TBL] [Abstract][Full Text] [Related]
11. Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors. Zhu J; Wang Z; Guo Z; Zhang X; Song T; Guo Y; Ji T; Zhang Z Arch Pharm (Weinheim); 2020 May; 353(5):e2000005. PubMed ID: 32175625 [TBL] [Abstract][Full Text] [Related]
12. Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents. Wan Y; Dai N; Tang Z; Fang H Eur J Med Chem; 2018 Feb; 146():471-482. PubMed ID: 29407973 [TBL] [Abstract][Full Text] [Related]
13. Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors. Du J; Liu L; Liu B; Yang J; Hou X; Yu J; Fang H Future Med Chem; 2020 Jul; 12(14):1293-1304. PubMed ID: 32397829 [No Abstract] [Full Text] [Related]
14. Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors. Liang X; Li X; Zhao Z; Nie Y; Yao Z; Ren W; Yang X; Hou X; Fang H Bioorg Chem; 2022 Apr; 121():105643. PubMed ID: 35150958 [TBL] [Abstract][Full Text] [Related]
15. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1. Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors. Liu T; Wan Y; Liu R; Ma L; Li M; Fang H Bioorg Med Chem; 2017 Mar; 25(6):1939-1948. PubMed ID: 28233676 [TBL] [Abstract][Full Text] [Related]
17. Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic. Zhang Z; Su P; Li X; Song T; Chai G; Yu X; Zhang K Arch Pharm (Weinheim); 2015 Feb; 348(2):89-99. PubMed ID: 25641608 [TBL] [Abstract][Full Text] [Related]
18. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins. Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799 [TBL] [Abstract][Full Text] [Related]
19. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1. Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106 [TBL] [Abstract][Full Text] [Related]